SCHEMBL20152908

SCHEMBL20152908

CC(=O)c1cccc2nc3n(c(=O)c12)CCNC3

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.35
POLB P06746 1/20 0.35
USP2 O75604 2/20 0.34
MAPK1 P28482 1/20 0.34
MCHR1 Q99705 1/20 0.34
KDM4E B2RXH2 3/20 0.34
HSD17B10 Q99714 2/20 0.34
CYP1A2 P05177 1/20 0.34
BCHE P06276 1/20 0.34
CFTR P13569 1/20 0.34
ALOX15 P16050 1/20 0.34
ACHE P22303 1/20 0.34
HKDC1 Q2TB90 1/20 0.34
GOPC Q9HD26 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KMT2A Q03164 4/20 0.34
PARP1 P09874 3/20 0.33
APOBEC3A P31941 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20036994 0.87 KDM4E (0.43) ALDH1A1USP2MAPK1MCHR1KDM4E
SCHEMBL20152906 0.72 PARP1 (0.45) POLBMAPK1PARP1
SCHEMBL20152907 0.69 PARP1 (0.42) ALDH1A1CYP1A2KMT2APARP1MEN1
SCHEMBL14550565 0.68 GAA (0.45) ALDH1A1POLBKDM4EHSD17B10CYP1A2
SCHEMBL839815 0.67 HTR2A (0.50) MCHR1KMT2AMEN1
SCHEMBL29539173 0.67 HTR2A (0.50) MCHR1KMT2AMEN1
Hydrochloric Acid SCHEMBL20139551 0.66 HTR2A (0.49) MCHR1KMT2AMEN1
SCHEMBL12059557 0.65 ALDH1A1 (0.40) ALDH1A1POLBUSP2MCHR1KDM4E
SCHEMBL6922315 0.65 ALDH1A1 (0.38) ALDH1A1USP2MCHR1KDM4EHSD17B10
SCHEMBL24097903 0.65 PDCD1 (0.34) ALDH1A1POLBTDP1L3MBTL1PDCD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134722-A1 AZA-PHENALENE-3-KETONE DERIVATIVE, PREPARATION METHOD THEREOF, AND ITS APPLICATION AS PARP INHIBITOR SUZHOU KANGRUN PHARMACEUTICALS INC. (CN) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134722-A1 AZA-PHENALENE-3-KETONE DERIVATIVE, PREPARATION METHOD THEREOF, AND ITS APPLICATION AS PARP INHIBITOR PARP1, PARP11, PARP3 ALDH1A1 812/4885POLB 586/4885USP2 3453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.